Eda SÜNNETÇİ, Aslı KIBRIS, Ferit DURANKUŞ

INVESTIGATING ASSOCIATED FACTORS BETWEEN ADMISSION TO PEDIATRIC EMERGENCY AND REFERRAL TO INTENSIVE CARE UNIT: A RETROSPECTIVE COHORT STUDY

Aim: We aimed to evaluate the patients who were admitted to Pediatric Emergency Department regarding the ratio of referral to Intensive Care Unit (ICU), and the relationship between the time of waiting in Emergency Department and the length of stay in Intensive Care Unit between January 2013 and December 2018. Materials and Methods: The patients’ records who were admitted to our Pediatric Emergency Department between January 2013 and December 2018 were evaluated retrospectively. The referrals to Neonatal and Pediatric ICU were evaluated. Due to the absence of an Intensive Care Unit in our hospital, we compared the duration of referral to ICU and length of stay in ICU. Results: The total number of patients who were admitted to Emergency Service was 673023, the number of the patients referred to ICU was 1327, 302 of these patients were referred to the Pediatric ICU (PICU), and the rest of them were referred to Neonatal ICU (NICU). While 47.35% of the patients who were referred to the PICU presented with respiratory tract diseases, 19.86% had neurological causes, 13.9% were intoxications, and 7.8% were gastrointestinal causes. 28.78% of the patients who were referred to the PICU had an accompanying chronic disease at the time of admission. Mean duration of referral to the PICU was 8.4 ± 6.3 hours. The length of stay of in PICU in 2017 and 2018 was investigated by asking on the phone (n = 122), and the mean length of stay of the patients in the PICU was 5.18 ± 2.1 days. There was no statistically significant correlation between the duration of referral to the ICU and the length of stay in the PICU (p; 0.089), whereas in 54 patients who presented to the emergency department due to respiratory distress and had no underlying chronic disease, there was a statistically significant correlation between the duration of referral to ICU and the length of stay in ICU (p: 0.012). Conclusion: The number of Pediatric Emergency Department admissions is very high in our country and most of these patients present with respiratory complaints. 0.19% of the patients who were admitted to the emergency service were in need of intensive care. Patients who had no underlying disease and who needed intensive care for respiratory distress were shown to have a shorter length of stay, and their referrals were faster. These patients should be referred to intensive care units without delay in the emergency service. As a conclusion, there is a need for more PICU in our country.

PDF

___

1. Fuchs CS, Enzinger PC, Meyerhardt J, et al. Adjuvant chemoradiotlherapy with epirubicin, cisplatin, and fluorouracil compared with adjuvant chemoradiotherapy with fluorouracil and leucovorin after curative resection of gastric cancer: Results from CALGB 80101 (Alliance). J Clin Oncol. 2017;35(32):3671-7.
2. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11-20.
3. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725-30.
4. Oken MM, Creech RH, Davis TE. Toxicology and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol Cancer Clin Trials. 1982;5(6): 649-55.
5. International Commission on Radiation Units and Measruments (1999) Prescribing, recording and reporting phptpn bean therapy (Supplement to ICRU report 50). ICRU 62 report. Oxford University Press.
6. Albano EA, Kanter JL.: Images in clinical medicine. Sister Mary Joseph’s nodule, N Eng J Med 2005;352: 1913
7. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006 Jan 21;12(3):354-62.
8. Park SH, Kim DY, Heo JS, et al. Postoperative chemoradiotherapy for gastric cancer. Ann Oncol. 2003;14(9):1373-77.
9. Archie V, Kauh J, Jones D V., Cruz V, Karpeh MS, Thomas CR. Gastric cancer: Standards for the 21st century. Crit Rev Oncol Hematol. 2006;57(2):123-31.
10. Oblak I, Velenik V, Anderluh F, Strojan P. Results of adjuvant radiochemotherapy for gastric adenocarcinoma in Slovenia. Eur J Surg Oncol. 2007;33(8):982-87.
11. Orditura M, Martinelli E, Galizia G, et al. Chemoradiotherapy as adjuvant treatment of gastric cancer. In: Annals of Oncology. Vol 18. ; 2007.
12. Lauren P. the two hıstologıcal maın types of gastrıc carcınoma: dıffuse and so-called ıntestınal-type carcınoma. an attempt at a hısto-clınıcal classıfıcatıon. acta pathol microbiol scand. 1965;64:31-49.
13. Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21(19):3647-650.
14. Roukos DH, Paraskevaidis E, Agnantis NJ, et al. Fruits and vegetables: Do they protect from gastric cancer? [7] (multiple letters). Gastroenterology. 2003;124(7):2006-7.
15. Persiani R, Rausei S, Biondi A, Boccia S, Cananzi F, D’Ugo D. Ratio of metastatic lymph nodes: Impact on staging and survival of gastric cancer. Eur J Surg Oncol. 2008;34(5):519-24.
16. Kim Y, Park SH, Kim KM, et al. The influence of metastatic lymph node ratio on the treatment outcomes in the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) trial: A phase III trial. J Gastric Cancer. 2016;16(2):105-110.
17. Fuchs CS, Enzinger PC, Meyerhardt J, et al. Adjuvant chemoradiotlherapy with epirubicin, cisplatin, and fluorouracil compared with adjuvant chemoradiotherapy with fluorouracil and leucovorin after curative resection of gastric cancer: Results from CALGB 80101 (Alliance). J Clin Oncol. 2017;35(32):3671-3677.
18. D’Elia F, Zingarelli A, Palli D, Grani M. Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases. Eur Radiol. 2000;10(12):1877-85.
19. Kienle P, Buhl K, Kuntz C, et al. Prospective comparison of endoscopy, endosonography and computed tomography for staging of tumours of the oesophagus and gastric cardia. Digestion. 2002;66(4):230-36.
20. 20. Shlomo Alani, V Soyfer, N Strauss, D Schifter, BW Corn. Limited advantages of intensity- modulated radiotherapy over 3D conformal radiation therapy in the adjuvant management of gastric cancer.Int J Radiation Oncology Biol Phys; 2009; 74: 562-66.